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Abstract
Purpose Catheter-associated bacteriuria (CAB) with
transurethral catheters is almost inevitable. Suprapubic
catheters (SPCs) are widely considered to decrease the risk
of CAB. However, SPCs are implants similarly prone to
microbial biofilm formation. The spectrum of colonising
pathogens has not been investigated. The aim of this pro-
spective study was: (1) to assess the diversity of microbial
suprapubic catheter colonisation (MSPCC), (2) to identify
risk factors and (3) to investigate its association with CAB
and catheter-associated urinary tract infection (CA-UTI).
Methods A total of 218 SPCs from 112 patients were
studied. Urine specimens were obtained after device
replacement or removal. Sonication was performed to dis-
lodge adherent microorganisms. Data of patient sex, age,
indwelling time, and underlying disease were recorded.
Results Sonicate-fluid culture (SFC) detected MSPCC in
95 %. Increasing indwelling time correlated with MSPCC
(p \ 0.05). Negative SFC was more frequent when anti-
biotic prophylaxis was applied at time of catheter place-
ment (15 vs. 2 %, p \ 0.05). Most commonly isolated were
Enterobacteriaceae (45.8 %), followed by Enterococcus
spp. (25.7 %) and Pseudomonas aeruginosa (10.3 %).
CAB and CA-UTI were observed in 95 and 11 %,
respectively.
Conclusions This study provides the first analysis of
MSPCC. Indwelling time increases, whereas antibiotic
prophylaxis decreases the risk of MSPCC. The spectrum of
pathogens is comparable to the one obtained from urethral
catheter biofilms. Urine specimens could not demonstrate
the microbial diversity of MSPCC. SPCs are not preferable
to urethral catheters to reduce CAB. Whether the risk of
CA-UTI could be minimised by SPCs remains to be clarified.
Keywords Biofilm  Catheter-associated bacteriuria 
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Introduction
Catheter-associated bacteriuria (CAB) with standard urinary
catheters is almost inevitable after prolonged catheterisation
[1]. Although frequently asymptomatic, CAB often precedes
catheter-associated urinary tract infection (CA-UTI) and
related complications [2, 3]. Suprapubic catheters (SPCs) are
widely considered as an alternative to short-term urethral
catheters to lower the risk of CAB or at least delay its onset
[4]. However, data are insufficient to make such a recom-
mendation for the long term [5]. In addition, the rate of CAB
in patients with suprapubic catheterisation is not as low as
expected [5, 6]. This might not be surprising as SPCs offer
pathogens from the skin a direct access to the bladder. Little
is known on microbial suprapubic catheter colonisation
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(MSPCC). The spectrum of colonising pathogens that may
be associated with ascending gram-negative bacteria from
the bladder or by gram-positive colonisation from the
insertion site has not been investigated yet. As microbial
biofilms have a major impact on medical devices or foreign
bodies placed in the urinary tract, further development of
effective methods to prevent their formation and related
complications is of utmost importance. However, such
innovations are most likely to be effective if they are based
on a solid understanding of pathogens involved. Therefore,
we designed a prospective observational trial to investigate
MSPCC. The rate of MSPCC and the spectrum of pathogens
were assessed, just as the association of MSPCC to CAB and
indwelling time. In addition, the influence of individual risk
factors from patients as well as different indications for SPC
placement was evaluated. In this study, we were using both
conventional urine culture and sonication as recently pub-
lished [7–9].
Materials and methods
Study population
All consecutive patients who had their suprapubic catheter
removed during the study period (1 March 2010 to 30
November 2010) were eligible for the study. The study was
approved by the local human subjects committee and com-
plied with the provisions of the Declaration of Helsinki,
Good Clinical Practice guidelines and local laws and regu-
lations. All included patients gave written informed consent.
Laboratory investigations
Suprapubic catheter sonication
Suprapubic catheters (silicone-based) were removed under
aseptic conditions in the operating theatre or in the outpatient
clinic. The catheter was divided into two segments (distal
and proximal). The proximal parts were discarded. The distal
segment included the tip of the catheter with the balloon
(bladder part) and the adjacent 5 cm. These parts were placed
in sterile tubes and processed by the microbiology laboratory
within 6 h. Negative controls (n = 8) consisted of unused
sterile SPCs unpacked in the operation room and sent for
sonication to go through the same process as SPCs removed
from the patients. Catheter colonisation was detected by
sonication as described previously [7–10].
Urine specimens
Urine specimens were obtained after device removal via
the freshly placed catheter or a midstream-voided urine
specimen if use of the catheter was discontinued. Speci-
mens were analysed by conventional culture methods,
outlined by the Manual of Clinical Microbiology, ASM,
following guidelines issued by CLSI.
Statistical analysis
Analyses were performed using SPSS version 17 software
(SPSS, Inc., Chicago, IL). McNemar’s and Chi-square test
were applied as appropriate. A p value of less than 0.05
was considered to indicate statistical significance. All tests
were two-sided.
Definitions
Positive sonicate-fluid culture (SFC)
Growth of C100 CFU/ml defined positive SFC. Since no
validated cut-off value for MSPCC diagnosed by sonica-
tion exists, the threshold of C102 CFU/ml was chosen
according to recommendations for intravascular catheters
[11].
Catheter-associated bacteriuria (CAB)
CA bacteriuria refers to catheter-associated urinary tract
infection (CA-UTI) and catheter-associated asymptomatic
bacteriuria (CA-ASB) combined.
Catheter-associated asymptomatic bacteriuria (CA-ASB)
CA-ASB is defined by the presence of C105 CFU/mL of
C1 bacterial species in a single catheter urine specimen in a
patient without symptoms compatible with UTI [5].
Catheter-associated urinary tract infection (CA-UTI)
CA-UTI is defined by the presence of symptoms or signs
(i.e. fever with no alternative source identified, suprapubic
pain, urgency, haematuria and catheter obstruction) com-
patible with UTI along with C103 CFU/mL of C1 bacterial
species [5].
Results
General characteristics
A total of 218 suprapubic catheters from 112 patients were
withdrawn during the study period. Two patients refused
consent, and in seven cases, urine at the time of catheter
removal was not submitted to the laboratory. Complete
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data of 209 catheter segments and urine specimens from
107 patients fulfilled the case definition and participated in
the study (Table 1).
Sonicate-fluid culture
Sonicate-fluid culture (SFC) detected MSPCC in 97 %.
The rate of colonisation increased with time of catheteri-
sation. SPCs in situ B14 days were significant less colon-
ised (67 %, p \ 0.05) compared to SPCs with an
indwelling time [14 days (89 %). Antimicrobial prophy-
laxis was associated with negative SFC (15 vs. 2 %,
p \ 0.05). No significant influence of gender and indica-
tion of SPC placement on the incidence of positive SFC
could be detected (Table 1). In a subset of paired cul-
tures—urine and sonication of the catheter—the yield of
sonication was significantly higher (n = 85, p \ 0.05).
Catheter-associated bacteriuria
CAB was observed in 95 % of the cases. Fifty-six per-
centage of urine specimens were eligible for further com-
parative analysis (Table 2) while 39 % were unsuitable due
to not identifiable polymicrobial microbial growth. Dura-
tion of suprapubic catheterisation increased the risk for
CAB (89 % short term vs. 96 % long term, p = 0.3).
Catheter-associated urinary tract infection
Overall, 23 cases (11 %) showed at least one symptom of
CA-UTI. Amongst these, 22 SPCs were associated with
both MSPCC and CAB. Duration of catheterisation
(C14 days) increased the risk for CA-UTI as all cases were
observed in long-term catheterised patients. The indication
for SPC placement did not influence the incidence of
CA-UTI.
Spectrum of organisms
SFC encountered a total of 428 organisms (Tables 2, 3)
that were differentiated in eight subgroups. Enterobacte-
riaceae spp. were most commonly cultured (45.8 %), fol-
lowed by Enterococcus spp. (25.7 %) and Pseudomonas
aeruginosa (10.3 %). A single pathogen grew in 59 %,
whereas 41 % of samples showed polymicrobial growth
(i.e. on average 2.15 microorganisms were per colonised
catheter); 56.5 % of isolated organisms were gram-nega-
tive, while 40.2 % were gram-positive and 3.3 % fungi,
respectively. Single species was detected in 23 % and
polymicrobial growth in 67 %. In cases with positive SFC
and positive urine culture SFC observed 81 additional
organisms (Table 2).
Table 1 Case characteristics
SPC suprapubic catheter, SFC
sonicate-fluid culture, CAB
catheter-associated bacteriuria,
CA-UTI catheter-associated
urinary tract infection, ABP
antibiotic prophylaxis
a Antibiotics applied consisted
of a single shot of ciprofloxacin,
cefpodoxime or amoxicillin
clavunate
Variables No. of catheters SFC positive SFC negative
Study group 209 (100 %) 199 (95 %) 10 (5 %)
Sex
Male 172 (82 %) 162 (94 %) 10 (6 %)
Female 37 (18 %) 37 (100 %) 0 (0 %)
CAB
Yes 199 (56 %) 194 (97 %) 5 (3 %)
No 10 (5 %) 5 (50 %) 5 (50 %)
CA-UTI
Yes 22 (11 %) 22 (100 %) 0 (0 %)
No 187 (89 %) 177 (95 %) 10 (5 %)
Indwelling time
Short term (B14 days) 9 (4 %) 6 (67 %) 3 (33 %)
Long term ([14 days) 200 (96 %) 193 (97 %) 7 (3 %)
Indication for SPC placement
Voiding dysfunction 81 (39 %) 77 (95 %) 4 (5 %)
Neurogenic voiding dysfunction 12 (6 %) 12 (100 %) 0 (0 %)
Fistula 5 (2 %) 3 (60 %) 2 (40 %)
Urethral stricture 26 (12 %) 23 (88 %) 3 (12 %)
Incontinence 33 (16 %) 33 (100 %) 0 (0 %)
Prostate cancer 22 (11 %) 21 (95 %) 1 (5 %)
Prostate enlargement 30 (14 %) 30 (100 %) 0 (0 %)
ABPa at SPC insertion 20 (10 %) 17 (85 %) 3 (15 %)
No ABP at SPC insertion 189 (90 %) 182 (96 %) 7 (4 %)
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Discussion
Suprapubic catheters (SPCs) are widely considered as
an alternative to urethral catheterisation. The presumed
advantages of SPCs are reduced risk of urethral trauma and
stricture formation, ability to attempt normal voiding
without the need for recatheterisation, less interference
with sexual activity and lower risk of CAB [6]. However,
Table 2 Results of sonicate-
fluid culture and urine culture
Brackets represent numbers
SFC sonicate-fluid culture, UC
urine culture, CoNS coagulase-
negative staphylococcus spp.
a Number of organisms
detected by sonication,
b concordant indicates that the
organism was isolated both
from sonicate-fluid and urine
cultures, c polymicrobial
microbial growth, not
identifiable
No. of
cases
No. of
organisms
Organism
Total 202 428a
Positive SFC and UC 116
Concordantb 94 111a Escherichia coli (45) Candida spp. (3)
Enterococcus spp. (31) Citrobacter freundii (2)
Staphylococcus aureus (9) Enterobacter cloacae (2)
CoNS (6) Actinobaculum schaalii (1)
Klebsiella spp. (5) Aerococcus urinae (1)
Pseudomonas
aeruginosa (5)
Proteus spp. (1)
Additional organisms
detected by SFC
81a
Enterococcus spp. (15) Coryne spp. (5)
Escherichia coli (15) Candida spp. (4)
Pseudomonas
aeruginosa (9)
Citrobacter freundii (3)
Staphylococcus
aureus (8)
Enterobacter cloacae (1)
Klebsiella spp. (7) Actinobaculum schaalii (1)
Proteus spp. (7) Stenotrophomonas
maltophilia (1)
CoNS (5)
Additional organisms
detected by UC
18 Escherichia coli (12) Enterobacter cloacae (1)
Enterococcus spp. (2) Staphylococcus aureus (1)
Pseudomonas
aeruginosa (2)
Discordant 22
Organisms
detected by SFC
45a Escherichia coli (13) Proteus spp. (3)
Enterobacter cloacae (8) CoNS (2)
Enterococcus spp. (7) Citrobacter freundii (1)
Pseudomonas
aeruginosa (6)
Staphylococcus aureus (1)
Klebsiella spp. (3) Serratia spp. (1)
Organisms detected
by UC
32 Enterococcus spp. (12) Proteus spp. (7)
Escherichia coli (12) Klebsiella spp. (1)
Positive SFC and
negative UC
5 10a Klebsiella spp. (3) Candida spp. (1)
Enterobacter cloacae (2) Enterococcus spp. (1)
Staphylococcus aureus (2) Escherichia coli (1)
Positive SFC
and UCc
81 181a Enterococcus spp. (56) CoNS (6)
Escherichia coli (38) Coryne spp. (6)
Pseudomonas
aeruginosa (24)
Enterobacter cloacae (4)
Klebsiella spp. (18) Actinobaculum schaalii (2)
Proteus spp. (11) Citrobacter freundii (1)
Staphylococcus aureus (7) Serratia spp. (1)
Candida spp. (6) Stenotrophomonas
maltophilia (1)
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SPCs offer microorganisms a direct access from the
insertion site into the bladder, rendering them at risk for
microbial colonisation and consecutive biofilm formation.
Antimicrobial treatment of biofilm infections is known to
be complicated as the microbial inhabitants may be up to a
1,000 times more resistant to antimicrobial therapy than
free-floating bacteria of the same species [12]. Antibiotics
often fail to penetrate the full depth of the biofilm. Fur-
thermore, pathogens of the biofilm have reduced growth
compared to free-floating bacteria. This makes them more
resistant against types of antibiotics that has its effect on
proliferating bacteria [13]. In contrast to urethral catheters
[14–16], data concerning biofilms on the surface of
suprapubic catheters (frequency, microbial diversity of
pathogens, relation to urine culture, etc.) appear not to
exist.
With our sonication system, we predominantly detected
Escherichia coli, Enterococcus spp. and Pseudomonas
aeruginosa. The same bacterial species were most com-
monly identified in urethral catheter biofilms [16]. This is a
rather surprising finding of our study, because the insertion
site of SPCs are away from the heavily colonised perineum
and periurethral skin both regarded to be responsible for
predominantly gram-negative biofilms on urethral cathe-
ters. We expected to detect mostly growth of gram-positive
organisms (i.e. Staphylococcus spp.). Staphylococcus spp.
constitute a significant part of the normal bacterial flora of
the human skin and could be easily introduced as a con-
taminant during the surgical implantation of suprapubic
catheters [17, 18]. Our findings might be interpreted as
follows: As important protective mechanisms of the uri-
nary tract (i.e. urine flow, regular bladder emptying and
valve mechanisms) are disabled in patients with SPCs,
gram-negative pathogens ascend via the urethra into the
bladder and colonise the surface of the suprapubic catheter.
As gram-negative organisms replicate faster than gram-
positive (e.g. Staphylococcus spp.) due to their thinner
murein cell wall, they could easily overgrow the primarily
gram-positive colonising flora of SPCs. The spectrum of
organisms identified by SFC did not differ between women
and men. This is in contrast urine cultures reported by
previous studies [19]. E. coli, the most common pathogen
within the subgroup of Enterobacteriaceae, uses several
virulence factors like hemolysins, cytotoxic necrotizing
factor, K1 capsule, siderophores as well as adhesins like
Type I pili and fimbrial protein fimH [20, 21]. Entero-
coccus spp. were reported to be the most common gram-
positive bacteria amongst uropathogens and have been
associated with biofilms on various kinds of indwelling
medical devices [22]. The formation of pili by Entero-
coccus spp. is necessary for biofilm formation. In addition,
the ‘enterococcal surface protein’ (Esp) has been shown to
promote the initial adherence of the bacterial cells to abi-
otic surfaces [23]. Pseudomonas aeruginosa was the third
most common isolated pathogen. Virulence of P. aeru-
ginosa is multifactorial and has been attributed to cell-
associated factors like alginate, lipopolysaccharide (LPS),
flagellum, pilus and non-pilus adhesins as well as with
exoenzymes or secretory virulence factors [24, 25]. SFC
could detect more microorganisms compared to urine cul-
ture. This is not surprising as urine culture can only detect
free floating, so-called planktonic organisms.
In this study, the frequency of CAB was comparable to
published data on patients with transurethral catheters
[6, 26, 27]. Therefore, suprapubic catheterisation is not
superior over to urethral catheters in the reduction CAB.
Whether the rate of CA-UTI could be reduced by the use
of SPCs remains speculative. Available literature is rare,
Table 3 Microorganisms detected by sonicate-fluid culture (male vs. female cases)
Organism Total no. Male sex Female sex
No. of organisms 428 R 343 R 85 R
Enterobacteriaceaea 196 (45.8 %) 1 156 (45.5 %) 1 40 (47.1 %) 1
Enterococcus spp. 110 (25.7 %) 2 88 (25.7 %) 2 22 (25.9 %) 2
Pseudomonas aeruginosa 44 (10.3 %) 3 33 (9.6 %) 3 11 (12.9 %) 3
Staphylococcus aureus 27 (6.3 %) 4 25 (7.3 %) 4 2 (2.4 %) 5
CoNSb 19 (4.4 %) 5 16 (4.7 %) 5 3 (3.5 %) 4
Candida spp. 14 (3.3 %) 6 11 (3.2 %) 6 3 (3.5 %) 4
Corynebacterium spp. 11 (2.6 %) 7 8 (2.3 %) 7 3 (3.5 %) 4
Otherc 7 (1.6 %) 8 6 (1.7 %) 8 1 (1.2 %) 6
R rank
a Escherichia coli (n = 112), Klebsiella spp. (n = 36), Proteus spp. (n = 22), Enterobacter cloacae (n = 17), Citrobacter freundii (n = 7),
Serratia spp. (n = 2)
b Coagulase-negative staphylococcus spp.
c Actinobaculum schaalii (n = 4), Stenotrophomonas maltophilia (n = 2), Aerococcus urinae (n = 1)
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inconsistent and controversial. A number of previous
studies used the term CAB without distinguishing CA-UTI
or CA-ASB. Moreover, the validity or reliability of
symptoms and/or signs distinguishing CA-UTI from
CA-ASB has not been critically evaluated yet [5, 6, 28–30].
The ideal interval to perform SPC replacement is diffi-
cult to define and might be adjusted on an individual basis.
Taking the low complication rate observed into account, a
routine change every 2–3 month seems to be justified.
Although we observed a significant effect of antibiotic
prophylaxis (ABP) on catheter colonisation, we agree
with current guidelines [4, 5] not to apply ABP routinely
due to the concern about selection of antimicrobial
resistance. In addition, even in cases where AB was
applied, the colonisation rate was high. With the
increasing number of biomaterial devices used in human
medicine, having an effective method for preventing
biofilm formation is of utmost importance [13]. Innova-
tions to prevent biofilm formation and related compli-
cations are most likely to be effective, if they are based
on a solid understanding of pathogens involved. There-
fore, our findings could be helpful to improve (i) the
development of new biomaterials to reduce biofilm for-
mation on urinary catheters, (ii) the addition or
impregnation of antimicrobial agents and (iii) the use of
probiotics to delay or prevent urinary catheter colonisa-
tion and associated complications. Some limitations of
this study should be mentioned: (1) The current lack of a
gold standard definition of SPC associated UTI (2), no
validated gold standard technique for the diagnosis of
MSPCC exist and (3) the cut-off value of SFC for
MSPCC was chosen according to a reference for intra-
vascular catheters.
Conclusion
This study provides the first report of microorganisms
colonising SPCs. MSPCC is common. The only identified
risk factor for MSPCC is indwelling time. Antibiotic pro-
phylaxis reduces MSPCC significantly and, however, could
not be recommended for daily practice due to the concern
about selection of resistant pathogens. The spectrum of
pathogens identified is comparable to urethral catheter
biofilms, indicating an infection route from the bladder
inside. Urine culture could not demonstrate the microbial
diversity of MSPCC. Whether the risk of CA-UTI could be
minimised by suprapubic catheterisation remains to be
clarified by further well-conducted studies.
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